Laramie, Wyoming – Disruptive MedTech (DMTI) recently received United States Food and Drug Administration Registration as a medical device establishment. DMTI is an ISO 13485 Group Manufacturing Organization, as well as an importer of record for 1000s of 501K FDA approved systems.
DMTI specializes as a GMO partnering with companies such as Marrow Access Technologies in production of the MAT SmartShot device, now being sold to hospitals and orthopedic surgery centers across the United States.